Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
J Urol. 2010 Oct;184(4):1347-53. doi: 10.1016/j.juro.2010.06.016. Epub 2010 Aug 17.
We assessed the prognostic significance of extranodal extension, defined as tumor extension through the lymph node capsule into the perinodal fibrous-adipose tissue, as well as several other risk factors in node positive penile cancer cases.
We analyzed prospectively collected data on a consecutive series of 156 chemotherapy naïve patients with proven lymph node involvement who underwent therapeutic regional lymphadenectomy. Postoperative external radiotherapy was indicated when histopathological analysis revealed more tumor than 1 intranodal metastasis. We estimated cancer specific survival using the Kaplan-Meier method. Multivariate analysis was done according to the Cox proportional hazards model of factors statistically significant on univariate analysis.
Adjuvant radiotherapy was done in 70 patients (45%). Median followup was 57.8 months. Overall 5-year cancer specific survival was 61%. Men with extranodal extension had significantly decreased 5-year cancer specific survival compared with men without it (42% vs 80%). Other prognostic variables on univariate analysis were bilateral metastatic involvement vs unilateral, 3 or greater unilateral metastatic inguinal nodes vs 2 or fewer, inguinal lymphadenectomy positive margin status vs negative status and pelvic lymph node involvement. Pathological T stage or differentiation grade were not significant predictors of outcome. On multivariate analysis extranodal extension and pelvic lymph node involvement remained associated with decreased cancer specific survival (HR 2.37 and 2.20, respectively).
Metastatic inguinal lymph node extranodal extension and pelvic lymph node involvement are independent predictive parameters of cancer specific survival in patients with pathologically node positive penile carcinoma despite surgery with postoperative radiotherapy.
我们评估了肿瘤侵犯淋巴结被膜并延伸至淋巴结周围纤维脂肪组织(定义为结外侵犯),以及其他一些风险因素在阳性淋巴结阴茎癌病例中的预后意义。
我们分析了 156 例经证实有淋巴结受累且未经化疗的连续患者的前瞻性收集数据,这些患者均接受了治疗性区域淋巴结切除术。当组织病理学分析显示肿瘤比 1 个淋巴结内转移更多时,建议行术后外放射治疗。我们使用 Kaplan-Meier 方法估计癌症特异性生存率。根据单因素分析中具有统计学意义的因素,采用 Cox 比例风险模型进行多因素分析。
70 例(45%)患者接受了辅助放疗。中位随访时间为 57.8 个月。总体 5 年癌症特异性生存率为 61%。有结外侵犯的男性与无结外侵犯的男性相比,5 年癌症特异性生存率显著降低(42%比 80%)。单因素分析中的其他预后变量包括双侧转移性受累与单侧、3 个或更多单侧腹股沟淋巴结转移与 2 个或更少、腹股沟淋巴结清扫阳性切缘与阴性和盆腔淋巴结受累。病理 T 分期或分化程度不是预后的显著预测因素。多因素分析显示,结外侵犯和盆腔淋巴结受累仍然与癌症特异性生存率降低相关(HR 分别为 2.37 和 2.20)。
尽管术后行放疗,但转移性腹股沟淋巴结结外侵犯和盆腔淋巴结受累是病理阳性阴茎癌患者癌症特异性生存率的独立预测参数。